Archive - 2012
17 December 2012 - Press Releases
Collaboration with Babraham Institute to explore PI3 kinase inhibitors in the treatment of inflammatory diseases
Karus Therapeutics Announces Collaboration with Babraham Institute to Explore PI3 Kinase Inhibitors in the Treatment of Inflammatory Diseases
06 September 2012 - Press Releases
Karus Therapeutics secures Series B financing from a syndicate of leading VC investors
Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche of $7.6 million.